Cardinal Health (CAH) Stock Forecast & Price Target

Compare

2,305 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

CAH Analyst Ratings

Strong Buy

11 Buy

2 Hold

0 Sell

Based on 13 analysts giving stock ratings to

Cardinal

Health

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

CAH Stock 12 Month Forecast

Average Price Target

$183.46

▲(22.67% Upside)

Based on 13 Wall Street analysts offering 12 month price targets for Cardinal Health in the last 3 months. The average price target is $183.46 with a high forecast of $203.00 and a low forecast of $161.00. The average price target represents a 22.67% change from the last price of $149.55.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"100":"$100","126":"$126","152":"$152","178":"$178","204":"$204"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":203,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$203.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":183.46,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$183.46</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":161,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$161.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[100,126,152,178,204],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,156,159.6153846153846,163.23076923076923,166.84615384615384,170.46153846153845,174.07692307692307,177.69230769230768,181.30769230769232,184.92307692307693,188.53846153846155,192.15384615384616,195.76923076923077,199.3846153846154,{"y":203,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,156,158.1123076923077,160.2246153846154,162.33692307692309,164.44923076923078,166.56153846153848,168.67384615384617,170.78615384615384,172.89846153846153,175.01076923076923,177.12307692307692,179.23538461538462,181.3476923076923,{"y":183.46,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,156,156.3846153846154,156.76923076923077,157.15384615384616,157.53846153846155,157.92307692307693,158.30769230769232,158.69230769230768,159.07692307692307,159.46153846153845,159.84615384615384,160.23076923076923,160.6153846153846,{"y":161,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":101.79,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":110.98,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":109.12,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":114.86,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":121.13,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":116.98,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":122.83,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":128.61,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":136.71,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":145.09,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":154.78,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":164.4,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":156,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$203.00

Average Price Target$183.46

Lowest Price Target$161.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Owen Mediport

TR | OpenAI - 4o

$164→$155

Hold

3.64%

Upside

Reiterated

08/23/25

AI Generated ArticleAI Generated Article

Steven Silver

Argus Research

$185→$189

Buy

26.38%

Upside

Reiterated

08/22/25

Cardinal Health price target raised to $189 from $185 at ArgusCardinal Health price target raised to $189 from $185 at Argus

Erin Wright

Morgan Stanley

$190

Buy

27.05%

Upside

Reiterated

08/13/25

Cardinal Health: Strategic Acquisitions and Raised Guidance Justify Buy Rating

Eric Coldwell

Robert W. Baird

$197→$203

Buy

35.74%

Upside

Reiterated

08/13/25

Cardinal Health price target raised to $203 from $197 at BairdCardinal Health price target raised to $203 from $197 at Baird

Allen Lutz

Bank of America Securities

$180

Buy

20.36%

Upside

Reiterated

08/13/25

Cardinal Health's Growth Potential: Buy Rating Reaffirmed Amid Strong Pharma Performance and Strategic Focus

Michael Cherny

Leerink Partners

$188→$186

Buy

24.37%

Upside

Reiterated

08/13/25

Cardinal Health price target lowered to $186 from $188 at LeerinkCardinal Health price target lowered to $186 from $188 at Leerink

Daniel Grosslight

Citi

$170→$165

Hold

10.33%

Upside

Reiterated

08/13/25

Citi Remains a Hold on Cardinal Health (CAH)

Stephen Baxter

Wells Fargo

$183→$185

Buy

23.70%

Upside

Reiterated

08/13/25

Cardinal Health price target raised to $185 from $183 at Wells FargoCardinal Health price target raised to $185 from $183 at Wells Fargo

Elizabeth Anderson CFA

Evercore ISI

$200→$190

Buy

27.05%

Upside

Reiterated

08/13/25

Evercore ISI Sticks to Its Buy Rating for Cardinal Health (CAH)

Lisa Gill

J.P. Morgan

$175→$178

Hold

19.02%

Upside

Reiterated

08/12/25

J.P. Morgan Keeps Their Hold Rating on Cardinal Health (CAH)

Charles Rhyee

TD Cowen

$162→$183

Buy

22.37%

Upside

Reiterated

08/12/25

Cardinal Health's Strong Performance and Strategic Initiatives Justify Buy Rating

Brian Tanquilut

Jefferies

$170→$190

Buy

27.05%

Upside

Reiterated

06/17/25

Cardinal Health (CAH) Receives a Buy from Jefferies

Kevin Caliendo

UBS

$170→$185

Buy

23.70%

Upside

Reiterated

06/16/25

UBS Keeps Their Buy Rating on Cardinal Health (CAH)

Steven Valiquette

Mizuho Securities

$150→$161

Buy

7.66%

Upside

Reiterated

06/06/25

Cardinal Health (CAH) Gets a Buy from Mizuho Securities

George Hill

Deutsche Bank

$124→$131

Hold

-12.40%

Downside

Reiterated

01/31/25

Cardinal Health (CAH) PT Raised to $131 at Deutsche BankDeutsche Bank analyst George Hill raised the price target on Cardinal Health (NYSE: CAH) to $131.00 (from $124.00) while maintaining a Hold rating.

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Owen Mediport

TR | OpenAI - 4o

$164→$155

Hold

3.64%

Upside

Reiterated

08/23/25

AI Generated ArticleAI Generated Article

Steven Silver

Argus Research

$185→$189

Buy

26.38%

Upside

Reiterated

08/22/25

Cardinal Health price target raised to $189 from $185 at ArgusCardinal Health price target raised to $189 from $185 at Argus

Erin Wright

Morgan Stanley

$190

Buy

27.05%

Upside

Reiterated

08/13/25

Cardinal Health: Strategic Acquisitions and Raised Guidance Justify Buy Rating

Eric Coldwell

Robert W. Baird

$197→$203

Buy

35.74%

Upside

Reiterated

08/13/25

Cardinal Health price target raised to $203 from $197 at BairdCardinal Health price target raised to $203 from $197 at Baird

Allen Lutz

Bank of America Securities

$180

Buy

20.36%

Upside

Reiterated

08/13/25

Cardinal Health's Growth Potential: Buy Rating Reaffirmed Amid Strong Pharma Performance and Strategic Focus

Michael Cherny

Leerink Partners

$188→$186

Buy

24.37%

Upside

Reiterated

08/13/25

Cardinal Health price target lowered to $186 from $188 at LeerinkCardinal Health price target lowered to $186 from $188 at Leerink

Daniel Grosslight

Citi

$170→$165

Hold

10.33%

Upside

Reiterated

08/13/25

Citi Remains a Hold on Cardinal Health (CAH)

Stephen Baxter

Wells Fargo

$183→$185

Buy

23.70%

Upside

Reiterated

08/13/25

Cardinal Health price target raised to $185 from $183 at Wells FargoCardinal Health price target raised to $185 from $183 at Wells Fargo

Elizabeth Anderson CFA

Evercore ISI

$200→$190

Buy

27.05%

Upside

Reiterated

08/13/25

Evercore ISI Sticks to Its Buy Rating for Cardinal Health (CAH)

Lisa Gill

J.P. Morgan

$175→$178

Hold

19.02%

Upside

Reiterated

08/12/25

J.P. Morgan Keeps Their Hold Rating on Cardinal Health (CAH)

Charles Rhyee

TD Cowen

$162→$183

Buy

22.37%

Upside

Reiterated

08/12/25

Cardinal Health's Strong Performance and Strategic Initiatives Justify Buy Rating

Brian Tanquilut

Jefferies

$170→$190

Buy

27.05%

Upside

Reiterated

06/17/25

Cardinal Health (CAH) Receives a Buy from Jefferies

Kevin Caliendo

UBS

$170→$185

Buy

23.70%

Upside

Reiterated

06/16/25

UBS Keeps Their Buy Rating on Cardinal Health (CAH)

Steven Valiquette

Mizuho Securities

$150→$161

Buy

7.66%

Upside

Reiterated

06/06/25

Cardinal Health (CAH) Gets a Buy from Mizuho Securities

George Hill

Deutsche Bank

$124→$131

Hold

-12.40%

Downside

Reiterated

01/31/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cardinal Health

1 Month

xxx

Success Rate

10/16 ratings generated profit

Average Return

+3.16%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 62.50% of your transactions generating a profit, with an average return of +3.16% per trade.

3 Months

xxx

Success Rate

12/16 ratings generated profit

Average Return

+5.17%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +5.17% per trade.

1 Year

Kevin CaliendoUBS

Success Rate

15/16 ratings generated profit

Average Return

+23.99%

reiterated a buy rating 3 months ago

Copying Kevin Caliendo's trades and holding each position for 1 Year would result in 93.75% of your transactions generating a profit, with an average return of +23.99% per trade.

2 Years

xxx

Success Rate

22/23 ratings generated profit

Average Return

+39.01%

reiterated a xxx

rating 22 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 95.65% of your transactions generating a profit, with an average return of +39.01% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CAH Analyst Recommendation Trends

Rating

Apr 25

May 25

Jun 25

Jul 25

Aug 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CAH has received 27 Buy Ratings, 10 Hold Ratings, and 0 Sell Ratings. CAH average Analyst price target in the past 3 months is 183.46.

Each month's total comprises the sum of three months' worth of ratings.

CAH Financial Forecast

CAH Earnings Forecast

Next quarter’s earnings estimate for CAH is $2.19 with a range of $2.10 to $2.42. The previous quarter’s EPS was $2.08. CAH beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.20% of the time in the same period. In the last calendar year CAH has Outperformed its overall industry.

CAH Sales Forecast

Next quarter’s sales forecast for CAH is $59.35B with a range of $57.57B to $60.24B. The previous quarter’s sales results were $60.16B. CAH beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 47.29% of the time in the same period. In the last calendar year CAH has Outperformed its overall industry.

CAH Stock Forecast FAQ

What is CAH’s average 12-month price target, according to analysts?

Based on analyst ratings, Cardinal Health’s 12-month average price target is 183.46.

What is CAH’s upside potential, based on the analysts’ average price target?

Cardinal Health has 22.67% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is CAH a Buy, Sell or Hold?

Cardinal Health has a consensus rating of Strong Buy which is based on 11 buy ratings, 2 hold ratings and 0 sell ratings.

What is Cardinal Health’s price target?

The average price target for Cardinal Health is 183.46. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $203.00 ,the lowest forecast is $161.00. The average price target represents 22.67% Increase from the current price of $149.55.

What do analysts say about Cardinal Health?

Cardinal Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Streets Analysts.

How can I buy shares of CAH?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Cardinal Health (CAH) Stock Forecast & Price Target

CAH Analyst Ratings

CAH Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Cardinal Health

CAH Analyst Recommendation Trends

CAH Financial Forecast

CAH Earnings Forecast

CAH Sales Forecast

CAH Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts